COMMONWEALTH OF AUSTRALIA
Instrument number PB 29 of 2010
Amendment declaration under subsections 85(2) and 85(2AA) of the National Health Act 1953
Amendment determination under subsection 85(2A) of the National Health Act 1953
I, FELICITY McNEILL, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 85(2), 85(2A) and 85(2AA) of the National Health Act 1953.
Dated 26 March 2010
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment declaration and determination — drugs and medicinal preparations
This instrument commences on the day after registration on the Federal Register of Legislative Instruments, and prior to the commencement of
PB 14 of 2010.
2 Amendment of PB 14 of 2010
Schedule 1 amends PB 14 of 2010.
Schedule 1 Amendments
 Schedule 1, item dealing with Dabigatran etexilate
(a) omit from the column headed “Circumstances” (wherever occurring):
(b) omit from the column headed “Circumstances” (wherever occurring):